SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-006362
Filing Date
2024-03-04
Accepted
2024-03-04 08:00:21
Documents
16
Period of Report
2024-03-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20240303_8k.htm   iXBRL 8-K 27937
2 EXHIBIT 99.1 ex_633988.htm EX-99.1 19983
  Complete submission text file 0001437749-24-006362.txt   202854

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20240304.xsd EX-101.SCH 3872
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20240304_def.xml EX-101.DEF 13415
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20240304_lab.xml EX-101.LAB 17615
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20240304_pre.xml EX-101.PRE 13392
17 EXTRACTED XBRL INSTANCE DOCUMENT bcda20240303_8k_htm.xml XML 4708
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 24712877
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)